Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of LifeMD, Inc. regarding a class action lawsuit due to allegations of materially false and misleading statements made by the company during a specified class period [1]. Summary by Sections Allegations - The complaint alleges that during the class period from May 7, 2025, to August 5, 2025, LifeMD's management overstated the company's competitive position [1]. - It is claimed that the company recklessly raised its 2025 guidance without properly accounting for increasing customer acquisition costs in its RexMD segment and related to obesity treatment drugs like Wegovy and Zepbound [1]. - As a result, the statements made by the defendants regarding LifeMD's business, operations, and prospects were materially false and misleading [1]. Next Steps for Shareholders - Shareholders who purchased shares of LFMD during the specified timeframe are encouraged to register for the class action by October 25, 2025 [2]. - Upon registration, shareholders will be enrolled in a portfolio monitoring software to receive updates throughout the case lifecycle [2]. Firm's Mission - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors affected by deceit, fraud, and illegal business practices [3]. - The firm aims to ensure that companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions that inflated stock prices [3].

Core Viewpoint - Nutex Health Inc. is facing allegations of issuing materially false and misleading statements during the class period from August 8, 2024, to August 14, 2025, related to its financial reporting and business practices [1]. Group 1: Allegations Against Nutex Health Inc. - The complaint alleges that Nutex's third-party vendor, HaloMD, engaged in fraudulent activities to defraud insurance companies, leading to unsustainable revenue [1]. - Nutex is accused of overstating its remediation efforts regarding material weaknesses in its internal controls over financial reporting [1]. - The company improperly classified stock-based compensation obligations as equity instead of liabilities, increasing the risk of delayed financial report filings with the SEC [1]. Group 2: Class Action Details - Shareholders who purchased shares of Nutex during the specified class period are encouraged to register for the class action, with a deadline of October 21, 2025, to seek lead plaintiff status [2]. - Registered shareholders will receive updates through a portfolio monitoring software throughout the lifecycle of the case [2]. - Participation in the case incurs no cost or obligation for shareholders [2]. Group 3: Law Firm's Commitment - The Gross Law Firm aims to protect investors' rights against deceit and fraud, ensuring companies adhere to responsible business practices [3]. - The firm seeks recovery for investors who suffered losses due to misleading statements or omissions that inflated stock prices [3].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of PubMatic, Inc. regarding a class action lawsuit due to alleged misleading statements and omissions that affected the company's stock value during a specified period [1][2]. Group 1: Allegations and Impact - The class period for the allegations is from February 27, 2025, to August 11, 2025 [2]. - Allegations include that a major demand side platform buyer shifted clients to a new platform, leading to a reduction in ad spend and revenue for PubMatic [2]. - The complaint asserts that the defendants made materially false and misleading statements about the company's business and prospects, lacking a reasonable basis [2]. Group 2: Shareholder Actions - Shareholders are encouraged to register for the class action by the deadline of October 20, 2025, to potentially be appointed as lead plaintiffs [3]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's status [3]. Group 3: Law Firm's Mission - The Gross Law Firm aims to protect investors' rights and seeks recovery for those who suffered losses due to deceitful practices by companies [4]. - The firm emphasizes the importance of responsible business practices and corporate citizenship [4].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of LifeMD, Inc. regarding a class action lawsuit alleging that the company made materially false and misleading statements about its competitive position and financial guidance during the specified class period [1]. Summary by Relevant Sections Allegations - The complaint claims that during the class period from May 7, 2025, to August 5, 2025, LifeMD's management overstated the company's competitive position [1]. - It is alleged that the company was reckless in raising its 2025 guidance without properly accounting for increasing customer acquisition costs in its RexMD segment and related to obesity treatment drugs like Wegovy and Zepbound [1]. - As a result, the statements made by the defendants regarding LifeMD's business operations and prospects were materially false and misleading [1]. Next Steps for Shareholders - Shareholders who purchased shares of LifeMD during the specified timeframe are encouraged to register for the class action by October 25, 2025 [2]. - Upon registration, shareholders will be enrolled in a portfolio monitoring system to receive updates on the case [2]. Firm's Commitment - The Gross Law Firm is recognized for its commitment to protecting investors' rights against deceit and fraud, ensuring companies adhere to responsible business practices [3].

Core Viewpoint - The Gross Law Firm has announced a class action lawsuit against RxSight, Inc. for allegedly misleading shareholders regarding the company's performance and financial guidance during a specified class period [2][4]. Summary by Relevant Sections Allegations - The complaint claims that RxSight faced "adoption challenges" and structural issues leading to declines in sales and utilization [2]. - It is alleged that the company overstated the demand for its products [2]. - As a result of these issues, RxSight is unlikely to meet its previously issued financial guidance for fiscal year 2025 [2]. - The positive statements made by the defendants about the company's business and prospects were materially misleading and lacked a reasonable basis [2]. Class Period and Deadlines - The class period for the lawsuit is from November 7, 2024, to July 8, 2025 [2]. - Shareholders are encouraged to register for the class action by September 22, 2025, to be eligible for potential recovery [3]. Next Steps for Shareholders - Registered shareholders will be enrolled in a portfolio monitoring software to receive updates on the case [3]. - There is no cost or obligation for shareholders to participate in the case [3]. Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and fraud [4]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [4].

Core Viewpoint - The Gross Law Firm has announced a class action lawsuit against Flywire Corporation, alleging that the company made materially false and misleading statements regarding its revenue growth and the impact of permit and visa-related restrictions on its business [1][2]. Group 1: Allegations and Class Period - The class period for the lawsuit is from February 28, 2024, to February 25, 2025 [1]. - Allegations include overstating the strength and sustainability of Flywire's revenue growth and understating the negative impact of permit and visa-related restrictions on the business [1]. Group 2: Next Steps for Shareholders - Shareholders who purchased shares during the specified class period are encouraged to register for the class action by September 23, 2025 [2]. - Registered shareholders will receive updates through a portfolio monitoring software throughout the lifecycle of the case [2]. Group 3: About The Gross Law Firm - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and fraud [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [3].

Core Points - C3.ai, Inc. is facing a class action lawsuit due to allegations of providing misleading statements about its growth and the impact of its CEO's health on business operations [1][2] - The company announced disappointing preliminary financial results for Q1 of fiscal 2026 and reduced its revenue guidance for the full fiscal year 2026, attributing these issues to leadership reorganization and the CEO's health [1] - Following the announcement, C3.ai's stock price dropped approximately 25.58%, from $22.13 on August 8, 2025, to $16.47 on August 11, 2025 [1] Shareholder Information - Shareholders who purchased shares during the class period from February 26, 2025, to August 8, 2025, are encouraged to register for the class action and can do so without any cost or obligation [2] - The deadline for shareholders to seek lead plaintiff status is October 21, 2025 [2] Legal Representation - The Gross Law Firm is representing the shareholders and aims to protect investors' rights against deceit and fraud in business practices [3]

Core Viewpoint - Tronox Holdings plc is facing a class action lawsuit due to allegations of providing misleading statements about its financial health and sales forecasts, leading to a significant drop in stock price [2][3]. Group 1: Allegations and Financial Impact - The lawsuit claims that Tronox made overly positive statements while concealing material adverse facts about its commercial division and sales forecasts, which ultimately led to a decline in sales and increased costs [2]. - On July 30, 2025, Tronox reported a significant reduction in TiO2 sales, attributing the decline to a "softer than anticipated coatings season and heightened competitive dynamics," which resulted in a lowered full-year revenue guidance and a 60% reduction in dividends [2]. - Following the announcement, Tronox's stock price plummeted from $5.14 per share to $3.19 per share on July 31, 2025, marking a decline of approximately 38% in just one day [2]. Group 2: Class Action Details - Shareholders who purchased shares of Tronox during the class period from February 12, 2025, to July 30, 2025, are encouraged to register for the class action, with a deadline set for November 3, 2025 [3]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the status of the case [3]. - The Gross Law Firm, which is leading the class action, emphasizes its commitment to protecting investors' rights against deceit and fraud [4].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Unicycive Therapeutics, Inc. regarding a class action lawsuit due to alleged misleading statements and failure to disclose critical information during the specified class period [1][2]. Summary by Relevant Sections Allegations - The complaint alleges that Unicycive Therapeutics overstated its readiness to meet FDA manufacturing compliance requirements, as well as the regulatory prospects of its oxylanthanum carbonate new drug application [1]. - It is claimed that the public statements made by the defendants were materially false and misleading throughout the class period from March 29, 2024, to June 27, 2025 [1]. Class Action Details - Shareholders who purchased shares of UNCY during the class period are encouraged to register for the class action, with a deadline set for October 14, 2025 [2]. - Participants will be enrolled in a portfolio monitoring software to receive updates on the case's progress [2]. Law Firm's Mission - The Gross Law Firm aims to protect investors' rights against deceit, fraud, and illegal business practices, emphasizing the importance of responsible business conduct [3]. - The firm seeks recovery for investors who suffered losses due to misleading statements or omissions that led to artificial inflation of stock prices [3].

NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Semler Scientific, Inc. (NASDAQ: SMLR). Shareholders who purchased shares of SMLR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/semler-scientific-inc-loss-submission-form/?id=166133&from=3 CLASS PERIOD ...